Financing deal worth €15.0 million signed to support clinical development programme for masitinib Masitinib developed as a credible candidate for treating…
06-8-2013 — /EuropaWire/ — Researchers at Karolinska Institutet in Sweden have identified a new stabilizing agent of atherosclerotic plaques. These findings…